Cargando…
Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer
We report the first peptide based hDHFR inhibitors designed on the basis of structural analysis of dihydrofolate reductase (DHFR). A set of peptides were rationally designed and synthesized using solid phase peptide synthesis and characterized using nuclear magnetic resonance and enzyme immunoassays...
Autores principales: | Singh, Amrinder, Deshpande, Neha, Pramanik, Nilkamal, Jhunjhunwala, Siddharth, Rangarajan, Annapoorni, Atreya, Hanudatta S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816602/ https://www.ncbi.nlm.nih.gov/pubmed/29453377 http://dx.doi.org/10.1038/s41598-018-21435-5 |
Ejemplares similares
-
A Composite of Hyaluronic Acid-Modified Graphene Oxide
and Iron Oxide Nanoparticles for Targeted Drug Delivery and Magnetothermal
Therapy
por: Pramanik, Nilkamal, et al.
Publicado: (2019) -
Surface-Coated
Cerium Nanoparticles to Improve Chemotherapeutic
Delivery to Tumor Cells
por: Pramanik, Nilkamal, et al.
Publicado: (2022) -
Sustained AMPK Activation and Proline Metabolism Play Critical Roles in the Survival of Matrix-Deprived Transformed Cells
por: Saha, Manipa, et al.
Publicado: (2021) -
Tales of Dihydrofolate Binding to R67 Dihydrofolate
Reductase
por: Duff, Michael R., et al.
Publicado: (2015) -
Computational Development of Inhibitors of Plasmid-Borne Bacterial Dihydrofolate Reductase
por: Silva, Pedro J.
Publicado: (2022)